EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Targeted Degradation of Histone Deacetylase 8 Using Proteolysis Targeting Chimeras Technology: A Promising Approach for Glioblastoma Treatment

Jiranan Chotitumnavee iD, Peeratchai Seemaung, Rapeewan Settacomkul, Ratchanon Sukprasert, Yukihiro Itoh, Takayoshi Suzuki, Sirada Srihirun, Christopher Power, Pornpun Vivithanaporn

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s555228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Jiranan Chotitumnavee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Glioblastoma, Histone Deacetylases, Antineoplastic Agents, Histone Deacetylase Inhibitors. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHistone DeacetylasesAntineoplastic AgentsHistone Deacetylase InhibitorsRepressor ProteinsHumansProteolysis Targeting ChimeraCell ProliferationApoptosisDrug Screening Assays, AntitumorDose-Response Relationship, DrugStructure-Activity RelationshipProteolysisTumor Cells, CulturedCell Survival

Stichwörter der Autor:innen

HDAC8HDAC8 degradationPROTACapoptosiscell cycle arrestendoplasmic reticulum stress

Substanzen

Histone DeacetylasesHDAC8 protein, humanProteolysis Targeting ChimeraAntineoplastic AgentsHistone Deacetylase InhibitorsRepressor Proteins

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
  • Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.
  • Laboratory for Biomaterials and Bioengineering, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan.
  • SANKEN, The University of Osaka, Osaka, Japan.
  • Department of Medicine, University of Alberta, Alberta, Canada.

ORCID-Profile: Jiranan Chotitumnavee

Zitieren

APA

Chotitumnavee, J., Seemaung, P., Settacomkul, R., Sukprasert, R., Itoh, Y., Suzuki, T., Srihirun, S., Power, C., & Vivithanaporn, P. (2026). Targeted Degradation of Histone Deacetylase 8 Using Proteolysis Targeting Chimeras Technology: A Promising Approach for Glioblastoma Treatment. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s555228

Vancouver

Chotitumnavee J, Seemaung P, Settacomkul R, Sukprasert R, Itoh Y, Suzuki T, et al. Targeted Degradation of Histone Deacetylase 8 Using Proteolysis Targeting Chimeras Technology: A Promising Approach for Glioblastoma Treatment. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s555228

BibTeX
@article{Chotitumnavee2026,
  author = {Chotitumnavee, Jiranan and Seemaung, Peeratchai and Settacomkul, Rapeewan and Sukprasert, Ratchanon and Itoh, Yukihiro and Suzuki, Takayoshi and Srihirun, Sirada and Power, Christopher and Vivithanaporn, Pornpun},
  title = {Targeted Degradation of Histone Deacetylase 8 Using Proteolysis Targeting Chimeras Technology: A Promising Approach for Glioblastoma Treatment},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s555228}
}
Kostenlos starten →